Skip to main content
PMC home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1995 May 1;129(3):881–892. doi: 10.1083/jcb.129.3.881

Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate

PMCID: PMC2120440  PMID: 7730416

Abstract

The expression of tissue transglutaminase in skeletal tissues is strictly regulated and correlates with chondrocyte differentiation and cartilage calcification in endochondral bone formation and in maturation of tracheal cartilage (Aeschlimann, D., A. Wetterwald, H. Fleisch, and M. Paulsson. 1993. J. Cell Biol. 120:1461-1470). We now demonstrate the transglutaminase reaction product, the gamma-glutamyl- epsilon-lysine cross-link, in the matrix of hypertrophic cartilage using a novel cross-link specific antibody. Incorporation of the synthetic transglutaminase substrate monodansylcadaverine (amine donor) in cultured tracheal explants reveals enzyme activity in the pericellular matrix of hypertrophic chondrocytes in the central, calcifying areas of the horseshoe-shaped cartilages. One predominant glutaminyl substrate (amine acceptor) in the chondrocyte matrix is osteonectin as revealed by incorporation of the dansyl label in culture. Indeed, nonreducible osteonectin-containing complexes of approximately 65, 90, and 175 kD can be extracted from mature tracheal cartilage. In vitro cross-linking of osteonectin by tissue transglutaminase gives similar products of approximately 90 and 175 kD, indicating that the complexes in cartilage represent osteonectin oligomers. The demonstration of extracellular transglutaminase activity in differentiating cartilage, i.e., cross-linking of osteonectin in situ, shows that tissue transglutaminase-catalyzed cross-linking is a physiological mechanism for cartilage matrix stabilization.

Full Text

The Full Text of this article is available as a PDF (5.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aeschlimann D., Paulsson M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J Biol Chem. 1991 Aug 15;266(23):15308–15317. [PubMed] [Google Scholar]
  2. Aeschlimann D., Paulsson M., Mann K. Identification of Gln726 in nidogen as the amine acceptor in transglutaminase-catalyzed cross-linking of laminin-nidogen complexes. J Biol Chem. 1992 Jun 5;267(16):11316–11321. [PubMed] [Google Scholar]
  3. Aeschlimann D., Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb Haemost. 1994 Apr;71(4):402–415. [PubMed] [Google Scholar]
  4. Aeschlimann D., Wetterwald A., Fleisch H., Paulsson M. Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol. 1993 Mar;120(6):1461–1470. doi: 10.1083/jcb.120.6.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Barsigian C., Stern A. M., Martinez J. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators. J Biol Chem. 1991 Nov 25;266(33):22501–22509. [PubMed] [Google Scholar]
  6. Bolander M. E., Young M. F., Fisher L. W., Yamada Y., Termine J. D. Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid). Proc Natl Acad Sci U S A. 1988 May;85(9):2919–2923. doi: 10.1073/pnas.85.9.2919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boskey A. L. Mineral-matrix interactions in bone and cartilage. Clin Orthop Relat Res. 1992 Aug;(281):244–274. [PubMed] [Google Scholar]
  8. Clezardin P., Malaval L., Ehrensperger A. S., Delmas P. D., Dechavanne M., McGregor J. L. Complex formation of human thrombospondin with osteonectin. Eur J Biochem. 1988 Aug 1;175(2):275–284. doi: 10.1111/j.1432-1033.1988.tb14194.x. [DOI] [PubMed] [Google Scholar]
  9. Connellan J. M., Chung S. I., Whetzel N. K., Bradley L. M., Folk J. E. Structural properties of guinea pig liver transglutaminase. J Biol Chem. 1971 Feb 25;246(4):1093–1098. [PubMed] [Google Scholar]
  10. Cornwell M. M., Juliano R. L., Davies P. J. Inhibition of the adhesion of Chinese hamster ovary cells by the naphthylsulfonamides dansylcadaverine and N-(6-aminohexyl)-5-chloro-1-naphthylenesulfonamide (W7). Biochim Biophys Acta. 1983 Jun 2;762(3):414–419. doi: 10.1016/0167-4889(83)90006-x. [DOI] [PubMed] [Google Scholar]
  11. Denhardt D. T., Guo X. Osteopontin: a protein with diverse functions. FASEB J. 1993 Dec;7(15):1475–1482. [PubMed] [Google Scholar]
  12. Dziadek M., Paulsson M., Aumailley M., Timpl R. Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. Eur J Biochem. 1986 Dec 1;161(2):455–464. doi: 10.1111/j.1432-1033.1986.tb10466.x. [DOI] [PubMed] [Google Scholar]
  13. Engel J., Taylor W., Paulsson M., Sage H., Hogan B. Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry. 1987 Nov 3;26(22):6958–6965. doi: 10.1021/bi00396a015. [DOI] [PubMed] [Google Scholar]
  14. Fesus L., Davies P. J., Piacentini M. Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol. 1991 Dec;56(2):170–177. [PubMed] [Google Scholar]
  15. Fisher L. W., Hawkins G. R., Tuross N., Termine J. D. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem. 1987 Jul 15;262(20):9702–9708. [PubMed] [Google Scholar]
  16. Folk J. E., Finlayson J. S. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem. 1977;31:1–133. doi: 10.1016/s0065-3233(08)60217-x. [DOI] [PubMed] [Google Scholar]
  17. Gentili C., Bianco P., Neri M., Malpeli M., Campanile G., Castagnola P., Cancedda R., Cancedda F. D. Cell proliferation, extracellular matrix mineralization, and ovotransferrin transient expression during in vitro differentiation of chick hypertrophic chondrocytes into osteoblast-like cells. J Cell Biol. 1993 Aug;122(3):703–712. doi: 10.1083/jcb.122.3.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hale J. E., Wuthier R. E. The mechanism of matrix vesicle formation. Studies on the composition of chondrocyte microvilli and on the effects of microfilament-perturbing agents on cellular vesiculation. J Biol Chem. 1987 Feb 5;262(4):1916–1925. [PubMed] [Google Scholar]
  19. Hohl D., Mehrel T., Lichti U., Turner M. L., Roop D. R., Steinert P. M. Characterization of human loricrin. Structure and function of a new class of epidermal cell envelope proteins. J Biol Chem. 1991 Apr 5;266(10):6626–6636. [PubMed] [Google Scholar]
  20. Holmdahl R., Rubin K., Klareskog L., Larsson E., Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 1986 Mar;29(3):400–410. doi: 10.1002/art.1780290314. [DOI] [PubMed] [Google Scholar]
  21. Hunziker E. B., Schenk R. K. Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats. J Physiol. 1989 Jul;414:55–71. doi: 10.1113/jphysiol.1989.sp017676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ikeda T., Nomura S., Yamaguchi A., Suda T., Yoshiki S. In situ hybridization of bone matrix proteins in undecalcified adult rat bone sections. J Histochem Cytochem. 1992 Aug;40(8):1079–1088. doi: 10.1177/40.8.1619274. [DOI] [PubMed] [Google Scholar]
  23. Kelm R. J., Jr, Mann K. G. The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation. J Biol Chem. 1991 May 25;266(15):9632–9639. [PubMed] [Google Scholar]
  24. Kim I. G., Gorman J. J., Park S. C., Chung S. I., Steinert P. M. The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse. J Biol Chem. 1993 Jun 15;268(17):12682–12690. [PubMed] [Google Scholar]
  25. Kojima S., Nara K., Rifkin D. B. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol. 1993 Apr;121(2):439–448. doi: 10.1083/jcb.121.2.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kvedar J. C., Pion I. A., Bilodeau E. B., Baden H. P., Greco M. A. Detection of substrates of keratinocyte transglutaminase in vitro and in vivo using a monoclonal antibody to dansylcadaverine. Biochemistry. 1992 Jan 14;31(1):49–56. doi: 10.1021/bi00116a009. [DOI] [PubMed] [Google Scholar]
  27. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  28. Lankat-Buttgereit B., Mann K., Deutzmann R., Timpl R., Krieg T. Cloning and complete amino acid sequences of human and murine basement membrane protein BM-40 (SPARC, osteonectin). FEBS Lett. 1988 Aug 29;236(2):352–356. doi: 10.1016/0014-5793(88)80054-1. [DOI] [PubMed] [Google Scholar]
  29. Lee K. N., Maxwell M. D., Patterson M. K., Jr, Birckbichler P. J., Conway E. Identification of transglutaminase substrates in HT29 colon cancer cells: use of 5-(biotinamido)pentylamine as a transglutaminase-specific probe. Biochim Biophys Acta. 1992 Jul 22;1136(1):12–16. doi: 10.1016/0167-4889(92)90078-p. [DOI] [PubMed] [Google Scholar]
  30. Lee S. C., Kim I. G., Marekov L. N., O'Keefe E. J., Parry D. A., Steinert P. M. The structure of human trichohyalin. Potential multiple roles as a functional EF-hand-like calcium-binding protein, a cornified cell envelope precursor, and an intermediate filament-associated (cross-linking) protein. J Biol Chem. 1993 Jun 5;268(16):12164–12176. [PubMed] [Google Scholar]
  31. Lichti U., Ben T., Yuspa S. H. Retinoic acid-induced transglutaminase in mouse epidermal cells is distinct from epidermal transglutaminase. J Biol Chem. 1985 Feb 10;260(3):1422–1426. [PubMed] [Google Scholar]
  32. Lorand L., Conrad S. M. Transglutaminases. Mol Cell Biochem. 1984;58(1-2):9–35. doi: 10.1007/BF00240602. [DOI] [PubMed] [Google Scholar]
  33. Mackie E. J., Thesleff I., Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol. 1987 Dec;105(6 Pt 1):2569–2579. doi: 10.1083/jcb.105.6.2569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mason I. J., Taylor A., Williams J. G., Sage H., Hogan B. L. Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell 'culture shock' glycoprotein of Mr 43,000. EMBO J. 1986 Jul;5(7):1465–1472. doi: 10.1002/j.1460-2075.1986.tb04383.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Maurer P., Mayer U., Bruch M., Jenö P., Mann K., Landwehr R., Engel J., Timpl R. High-affinity and low-affinity calcium binding and stability of the multidomain extracellular 40-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin). Eur J Biochem. 1992 Apr 1;205(1):233–240. doi: 10.1111/j.1432-1033.1992.tb16773.x. [DOI] [PubMed] [Google Scholar]
  36. Mayer U., Aumailley M., Mann K., Timpl R., Engel J. Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur J Biochem. 1991 May 23;198(1):141–150. doi: 10.1111/j.1432-1033.1991.tb15996.x. [DOI] [PubMed] [Google Scholar]
  37. Metsäranta M., Young M. F., Sandberg M., Termine J., Vuorio E. Localization of osteonectin expression in human fetal skeletal tissues by in situ hybridization. Calcif Tissue Int. 1989 Sep;45(3):146–152. doi: 10.1007/BF02556057. [DOI] [PubMed] [Google Scholar]
  38. Nischt R., Pottgiesser J., Krieg T., Mayer U., Aumailley M., Timpl R. Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur J Biochem. 1991 Sep 1;200(2):529–536. doi: 10.1111/j.1432-1033.1991.tb16214.x. [DOI] [PubMed] [Google Scholar]
  39. Poole A. R., Pidoux I., Rosenberg L. Role of proteoglycans in endochondral ossification: immunofluorescent localization of link protein and proteoglycan monomer in bovine fetal epiphyseal growth plate. J Cell Biol. 1982 Feb;92(2):249–260. doi: 10.1083/jcb.92.2.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Prince C. W., Dickie D., Krumdieck C. L. Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem Biophys Res Commun. 1991 Jun 28;177(3):1205–1210. doi: 10.1016/0006-291x(91)90669-x. [DOI] [PubMed] [Google Scholar]
  41. Sage E. H., Bornstein P. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J Biol Chem. 1991 Aug 15;266(23):14831–14834. [PubMed] [Google Scholar]
  42. Sage H., Vernon R. B., Funk S. E., Everitt E. A., Angello J. SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix. J Cell Biol. 1989 Jul;109(1):341–356. doi: 10.1083/jcb.109.1.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Seitz J., Keppler C., Rausch U., Aumüller G. Immunohistochemistry of secretory transglutaminase from rodent prostate. Histochemistry. 1990;93(5):525–530. doi: 10.1007/BF00266412. [DOI] [PubMed] [Google Scholar]
  44. Solursh M. Differentiation of cartilage and bone. Curr Opin Cell Biol. 1989 Oct;1(5):989–994. doi: 10.1016/0955-0674(89)90070-7. [DOI] [PubMed] [Google Scholar]
  45. Staros J. V., Wright R. W., Swingle D. M. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem. 1986 Jul;156(1):220–222. doi: 10.1016/0003-2697(86)90176-4. [DOI] [PubMed] [Google Scholar]
  46. Stenner D. D., Tracy R. P., Riggs B. L., Mann K. G. Human platelets contain and secrete osteonectin, a major protein of mineralized bone. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6892–6896. doi: 10.1073/pnas.83.18.6892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sørensen E. S., Rasmussen L. K., Møller L., Jensen P. H., Højrup P., Petersen T. E. Localization of transglutaminase-reactive glutamine residues in bovine osteopontin. Biochem J. 1994 Nov 15;304(Pt 1):13–16. doi: 10.1042/bj3040013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Termine J. D., Belcourt A. B., Conn K. M., Kleinman H. K. Mineral and collagen-binding proteins of fetal calf bone. J Biol Chem. 1981 Oct 25;256(20):10403–10408. [PubMed] [Google Scholar]
  49. Termine J. D., Kleinman H. K., Whitson S. W., Conn K. M., McGarvey M. L., Martin G. R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell. 1981 Oct;26(1 Pt 1):99–105. doi: 10.1016/0092-8674(81)90037-4. [DOI] [PubMed] [Google Scholar]
  50. Thacher S. M., Rice R. H. Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell. 1985 Mar;40(3):685–695. doi: 10.1016/0092-8674(85)90217-x. [DOI] [PubMed] [Google Scholar]
  51. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Turner B. M. Histone acetylation and control of gene expression. J Cell Sci. 1991 May;99(Pt 1):13–20. doi: 10.1242/jcs.99.1.13. [DOI] [PubMed] [Google Scholar]
  53. Upchurch H. F., Conway E., Patterson M. K., Jr, Maxwell M. D. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J Cell Physiol. 1991 Dec;149(3):375–382. doi: 10.1002/jcp.1041490304. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES